Bruker (BRKR)
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
$58.50-1.53%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
QuarterlyIQ Insights · BRKR
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||
| Revenues | 3,499.6 | 3,436.5 | 3,366.4 | 2,964.5 | 2,530.7 | 2,417.9 | 1,987.5 | 2,072.6 | 1,895.6 | 1,765.9 | 1,611.3 | 1,623.8 | 1,808.9 | 1,839.4 | 1,791.4 | 1,651.7 |
| Total Revenues | — | — | — | — | — | — | — | — | 1,895.6 | 1,765.9 | 1,611.3 | 1,623.8 | 1,808.9 | 1,839.4 | 1,791.4 | 1,651.7 |
| Cost of Revenues | 1,875.2 | 1,858.8 | 1,716.9 | 1,451.2 | 1,225.0 | 1,208.3 | 1,047.7 | 1,077.3 | 995.6 | 949.9 | 866.0 | 915.2 | 1,045.6 | 1,034.2 | 962.0 | 899.2 |
| Gross Profit | 1,624.4 | 1,577.7 | 1,649.5 | 1,513.3 | 1,305.7 | 1,209.6 | 939.8 | 995.3 | 900.0 | 816.0 | 745.3 | 708.6 | 763.3 | 805.2 | 829.4 | 752.5 |
| Operating Expenses & Income | ||||||||||||||||
| Selling, General & Admin | 970.7 | 946.5 | 893.8 | 729.4 | 607.4 | 561.2 | 468.6 | 500.2 | 444.7 | 415.2 | 389.8 | 392.2 | 451.0 | 437.9 | 440.4 | 406.6 |
| R&D Expenses | 393.5 | 395.2 | 376.5 | 294.8 | 235.9 | 220.8 | 198.0 | 187.7 | 173.4 | 161.6 | 147.9 | 145.7 | 174.2 | 190.5 | 195.3 | 177.2 |
| Other Operating Expenses, Total | 4.7 | (1.2) | — | 3.7 | 1.3 | 0.0 | — | — | — | — | — | — | — | — | — | — |
| Operating Income | (30.6) | 68.2 | 253.1 | 436.9 | 432.7 | 413.3 | 248.3 | 300.9 | 262.4 | 219.5 | 181.8 | 145.7 | 105.4 | 148.2 | 156.0 | 155.6 |
| Earnings from Continuing Operations | ||||||||||||||||
| Interest Expense | — | 60.3 | 47.9 | 16.4 | 16.1 | 14.3 | 14.4 | 16.0 | 12.6 | 15.4 | 13.2 | 13.0 | 13.3 | 13.4 | 14.3 | 7.3 |
| Interest & Investment Income | 25.2 | 14.8 | 9.3 | 7.5 | 2.8 | 0.9 | 3.2 | 1.3 | 1.2 | 0.8 | 0.3 | 1.2 | 0.8 | 1.0 | 0.9 | 1.0 |
| Net Interest Expenses | — | — | — | 8.9 | 13.3 | 13.4 | 11.2 | 14.7 | 11.4 | 14.6 | 12.9 | 11.8 | 12.5 | 12.4 | 13.4 | 6.3 |
| Other Non-Operating Income / Expenses | 8.2 | (46.2) | (46.2) | 107.3 | (18.8) | (19.7) | (22.5) | (20.5) | (17.7) | (21.7) | (4.2) | (17.7) | (4.1) | (23.6) | (17.7) | — |
| Asset Writedown | — | 30.7 | 28.5 | 0.0 | 1.6 | 0.0 | 0.0 | — | 0.6 | 1.1 | 0.8 | 4.6 | 11.5 | 23.8 | 23.8 | 0.7 |
| EBT, Incl. Unusual Items | (22.4) | 22.0 | 206.9 | 544.2 | 413.9 | 393.6 | 225.8 | 280.4 | 244.7 | 197.8 | 177.6 | 128.0 | 101.3 | 124.6 | 138.3 | 145.5 |
| Income Tax Expense | 40.4 | 29.3 | 91.4 | 117.7 | 116.4 | 113.0 | 64.4 | 82.4 | 63.7 | 117.5 | 23.1 | 23.1 | 41.7 | 42.8 | 60.1 | 51.5 |
| Net Income | ||||||||||||||||
| Minority Interest | 6.7 | 0.3 | 0.7 | 1.3 | 1.9 | 3.5 | 3.6 | 0.8 | 1.3 | 1.7 | 0.9 | 3.3 | 2.9 | 1.7 | 0.7 | 1.7 |
| Net Income | (70.9) | (8.6) | 113.1 | 428.5 | 298.5 | 280.6 | 157.8 | 197.2 | 179.7 | 78.6 | 153.6 | 101.6 | 56.7 | 80.1 | 77.5 | 94.0 |
| Per Share | ||||||||||||||||
| Basic EPS | (0.47) | (0.15) | 0.76 | 2.92 | 2.00 | 1.83 | 1.03 | 1.27 | 1.15 | 0.50 | 0.95 | 0.60 | 0.34 | 0.48 | 0.47 | 0.56 |
| Diluted EPS | (0.47) | (0.15) | 0.76 | 2.90 | 1.99 | 1.81 | 1.02 | 1.26 | 1.14 | 0.49 | 0.95 | 0.60 | 0.33 | 0.48 | 0.46 | 0.55 |
| Revenue per Share | 22.98 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividend per Share | — | — | — | 0.20 | 0.16 | 0.16 | 0.16 | — | 0.16 | 0.16 | 0.16 | — | — | — | — | — |
| Basic Weighted Avg Shares | 152.3 | 151.8 | 0.0 | 146.4 | 0.0 | 0.0 | 0.0 | 0.0 | 156.2 | 158.1 | 161.4 | 168.2 | 167.8 | 166.5 | 166.0 | 165.4 |
| Diluted Weighted Avg Shares | 152.3 | 151.8 | 0.0 | 147.2 | 0.0 | 0.0 | 0.0 | 0.0 | 157.2 | 159.1 | 162.2 | 169.1 | 169.5 | 168.5 | 167.4 | 166.9 |
| Supplemental | ||||||||||||||||
| EBITDA | — | 288.5 | 436.9 | 551.8 | 521.5 | 502.4 | 328.7 | 376.5 | 327.3 | 283.4 | 236.1 | 199.0 | 165.1 | 209.5 | 215.1 | 208.5 |
| EBIT | (30.6) | 68.2 | 253.1 | 436.9 | 432.7 | 413.3 | 248.3 | 300.9 | 262.4 | 219.5 | 181.8 | 145.7 | 105.4 | 148.2 | 156.0 | 155.6 |
| Effective Tax Rate | -180.4% | — | — | 21.6% | 28.1% | 28.7% | 28.5% | 29.4% | 26.0% | 59.4% | 13.0% | 18.0% | 41.2% | 34.3% | 43.5% | 35.4% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.